Advertisement

Digestive Diseases and Sciences

, Volume 39, Issue 1, pp 152–156 | Cite as

Interleukin-1 receptor antagonist does not prevent endotoxin-induced inhibition of gastric acid secretion in rats

  • Esteban Saperas
  • Yvette Taché
Original Article

Abstract

The underlying mechanisms involved in endotoxin-induced inhibition of gastric acid secretion were investigated in conscious rats with pylorus ligation for 2 hr. Intraperitoneal injection of endotoxin (0.1, 1, and 5 µg/rat) inhibited gastric acid output by 31%, 80%, and 84% respectively. Intraperitoneal endotoxin (1 µg/rat) -induced inhibition of gastric acid secretion was not altered by pretreatment with the interleukin-1 receptor antagonist, IL-1RA, indomethacin, naloxone, or capsaicin. Treatments were injected peripherally at doses previously shown to antagonize the antisecretory effect of exogenous interleukin-1β, to inhibit prostaglandin synthesis in the stomach and brain, to block opiate receptors, and to alter functioning of unmyelinated afferent nerve fibers. These results indicate that the antisecretory effect of endotoxin can be expressed by factors other than interleukin-1, prostaglandins, or opioid peptides that do not require the integrity of capsaicin-sensitive afferent pathways.

Key words

endotoxin gastric acid secretion interleukin-1 receptor antagonist indomethacin capsaicin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bhalla S, Vij JC, Anand BS, Varghese A, Chuttani HK: Gastric acid secretion in patients with typhoid fever. Gut 26:491–494, 1985PubMedGoogle Scholar
  2. 2.
    Impicciatore M, Hansen DG, Rachmilewitz D, Maitra SK, Lugaro G, Grossman MI: Comparison of human urine gastric inhibitor (HUGI) and bacterial endotoxin as inhibitors of acid secretion. Eur J Pharmacol 65:365–368, 1980PubMedGoogle Scholar
  3. 3.
    Uehara A, Okumura T, Sekiya C, Okamura K, Takasugi Y, Namiki M: Interleukin-1 inhibits the secretion of gastric acid in rats: Possible involvement of prostaglandin. Biochem Biophys Res Commun 162:1578–1584, 1989PubMedGoogle Scholar
  4. 4.
    Tsuji K, Uehara A, Okumura T, et al: The gastric antisecretory action of lipopolysaccharide is blocked by indomethacin. Eur J Pharmacol 210:213–215, 1992PubMedGoogle Scholar
  5. 5.
    Uehara A, Okumura T, Tsuji K, et al: Evidence that gastric antisecretory action of lipopolysaccharide is not due to a toxic effect on gastric parietal cells. Dig Dis Sci 37:1039–1044, 1992PubMedGoogle Scholar
  6. 6.
    Ulich TR, Guo K, Irwin B, Remick DG, Navatelis GN: Endotoxin-induced cytokine gene expression in vivo. Am J Pathol 137:1173–1185, 1990PubMedGoogle Scholar
  7. 7.
    Sirko S, Bishai I, Coceani F: Prostaglandin formation in the hypothalamusin vivo: Effect of pyrogens. Am J Physiol 256:R616-R624, 1989PubMedGoogle Scholar
  8. 8.
    Zuckermam SH, Shellhaas J, Butler LD: Differential regulation of lipopolysaccharide-induced interleukin-1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of pituitary-adrenal axis. Eur J Immunol 19:301–307, 1989PubMedGoogle Scholar
  9. 9.
    Raymond RM, Harkema JM, Stoffs WV, Emerson TE: Effects of naloxone therapy on hemodynamics and metabolism following a superlethal dosage ofEscherichia coli endotoxin in dogs. Surg Gynecol Obstet 152:159–162, 1981PubMedGoogle Scholar
  10. 10.
    Ebisui O, Fukata J, Tominaga T, et al: Role of interleukin-1α and -1β in endotoxin-induced suppression of plasma gonadotropin levels in rats. Endocrinology 130:3307–3313, 1992PubMedGoogle Scholar
  11. 11.
    Rivier C, Chizzonite R, Vale W: In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology 125:2800–2805, 1989PubMedGoogle Scholar
  12. 12.
    Long NC, Otterness I, Kunkel SL, Vander AJ, Kluger MJ: Roles of interleukin 1β and tumor necrosis factor in lipopolysaccharide fever in rats. Am J Physiol 259:R724-R728, 1990PubMedGoogle Scholar
  13. 13.
    Hamilton AJ, Carr DB, Larovere JM, Black PMCL: Endotoxic shock elicits greater endorphin secretion than hemorrhage. Circ Shock 19:47–54, 1986PubMedGoogle Scholar
  14. 14.
    Carr DB, Bergland R, Hamilton A, et al: Endotoxin-stimulated opioid peptide secretion: Two secretory pools and feedback controlin vivo. Science 217:845–848, 1982PubMedGoogle Scholar
  15. 15.
    Rees M, Payne JG, Bowen JC: Naloxone reverses tissue effects of liveEscherichia coli sepsis. Surgery 91:81–86, 1982PubMedGoogle Scholar
  16. 16.
    Lundberg JM, Franco-Cereceda A, Alving K, Delay-Goyet P, Lou Y-P: Release of calcitonin gene-related peptide from sensory nerve. Ann NY Acad Sci 657:187–193, 1992PubMedGoogle Scholar
  17. 17.
    Saperas E, Yang H, Rivier C, Taché Y: Central action of recombinant interleukin-1 to inhibit acid secretion in rats. Gastroenterology 99:1599–1606, 1990PubMedGoogle Scholar
  18. 18.
    Ishikawa T, Nagato S, Ago Y, Takahashi K, Karibe M: The central inhibitory effect of interleukin-1 on gastric acid secretion. Neurosci Lett 119:114–117, 1990PubMedGoogle Scholar
  19. 19.
    Wallace JH, Keenan CM, Cucala M, Mugridge KG, Parente L: Mechanisms underlying the protective effects of interleukin 1 in experimental nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 102:1176–1185, 1992PubMedGoogle Scholar
  20. 20.
    Saperas E, Cominelli F, Taché Y: Potent inhibition of gastric acid secretion by intravenous interleukin-1β and -1α in rats. Peptides 13:221–226, 1992PubMedGoogle Scholar
  21. 21.
    Robert A, Olafsson AS, Lancaster C, Zyang WR: Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying. Life Sci 48:123–134, 1991PubMedGoogle Scholar
  22. 22.
    Wallace JL, Cucala M, Mugridge K, Parente L: Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 261:G559-G564, 1991PubMedGoogle Scholar
  23. 23.
    Saperas E, Kauffman G, Taché Y. Role of central prostaglandin E2 in the regulation of gastric acid secretion in the rat. Eur J Pharmacol 209:1–7, 1991PubMedGoogle Scholar
  24. 24.
    Fox DA, Burks TF: Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat. J Pharmacol Exp Ther 244:456–462, 1988PubMedGoogle Scholar
  25. 25.
    Taché Y: Inhibition of gastric acid secretion and ulcers by calcitonin gene-related peptide. Ann NY Acad Sci 657:240–247, 1992PubMedGoogle Scholar
  26. 26.
    Hannum CH, Wilcox CJ, Arend WP, et al: Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336–340, 1990PubMedGoogle Scholar
  27. 27.
    Dinarello CA, Thompson RC: Blocking IL-1: interleukin 1 receptor antagonistin vivo andin vitro. Immunol Today 12:404–410, 1991PubMedGoogle Scholar
  28. 28.
    Lenz JH, Marvin MR: Central nervous system actions of β-endorphin on gastric acid secretion. Brain Res 413:1–9, 1987PubMedGoogle Scholar
  29. 29.
    Holzer P: Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 43:143–201, 1991PubMedGoogle Scholar
  30. 30.
    Pique JM, Yonei Y, Whittle BJR, Leung FW, Guth PH: Indomethacin potentiates endotoxin-induced blood flow reduction and histological injury in rat gastric mucosa. Br J Pharmacol 93:925–931, 1988PubMedGoogle Scholar
  31. 31.
    Wallace JL: Gastrointestinal plasma leakage in endotoxin shock. Inhibition by prostaglandin E2 and a platelet-activating factor antagonist. Can J Physiol Pharmacol 65:1428–1432, 1987PubMedGoogle Scholar
  32. 32.
    Lieberman AP, Pitha PM, Shin HS, Shin ML: Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 86:6348–6352, 1989PubMedGoogle Scholar
  33. 33.
    Katsuura G, Gottschall PE, Arimura A: Identification of a high-affinity receptor for interleukin-1 beta in rat brain. Biochem Biophys Res Commun 156:61–67, 1988PubMedGoogle Scholar
  34. 34.
    Saperas E, Yang H, Taché Y: Interleukin-1β acts at hypothalamic sites to inhibit gastric acid secretion in rats. Am J Physiol 263:G414-G418, 1992PubMedGoogle Scholar
  35. 35.
    Saperas E, Taché Y. Central interleukin-1β-induced inhibition of acid secretion in rats: Specificity of action. Life Sci 52:785–792, 1993PubMedGoogle Scholar
  36. 36.
    Schweigerer L: Endotoxin-induced formation of specific β-endorphin binding sites in human serum. Biochem Biophys Res Commun 113:839–844, 1983PubMedGoogle Scholar
  37. 37.
    Sternini C: Enteric and visceral afferent CGRP neurons: Targets of innervation and differential expression patterns. Ann NY Acad Sci 657:170–186, 1992PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • Esteban Saperas
    • 1
    • 2
  • Yvette Taché
    • 1
    • 2
  1. 1.From the CURE/Digestive Disease Center, VA Wadsworth Medical Center, Department of Medicine and Brain Research InstituteUCLALos Angeles
  2. 2.the Digestive System Research UnitHospital Vall d'HebronBarcelonaSpain

Personalised recommendations